Abiopharma

🔍 WEITZMAN DEBORAH (Executive)

Company: CARDINAL HEALTH INC (CAH)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Sold 6,665 shares of Common Shares at $235.3 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 78,590.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 408 shares of Common Shares at $236.59 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 78,182.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 281 shares of Common Shares at $237.44 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 77,901.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.17 to $236.02, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1, 2, and 3 to this Form 4.
• F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.24 to $237.143, inclusive.
• F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.2615 to $237.6285, inclusive.